Ophthalmology Drugs Market 2022: SWOT Analysis Of Key Driving Factors For Growing CAGR Value | Novartis AG, Regeneron Pharmaceuticals, Inc., Allergan plc, Bayer AG
According to The Business Research Company's ophthalmology drugs market report, the global ophthalmology drugs market is expected to decline from $24,640.0 million in 2019 to $19,831.3 million in 2020 at a compound annual growth rate (CAGR) of -19.5%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 44.6% from 2021 and reach $33,272.8 million in 2023. The market is expected to grow at a CAGR of 7.2% to nearly $38,223.53 million by 2025, and at a CAGR of 7.0% to $53,698.87 million by 2030.
Increasing incidence and prevalence of eye diseases causing vision loss or blindness and age-related eye diseases is expected to support the growth of the ophthalmic drugs market. Eye disorders such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and cataract are becoming major causes of visual impairment and blindness globally.
View Our Buying Options For The Ophthalmology drugs market Report Here:
The ophthalmology drugs market is segmented -
• By Drug Type- Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmology Drugs
• By Prescription Type- OTC Drugs, Prescription Drugs
• By Distribution Channel- Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies
• By Drug Variation- Branded Drugs, Generic Drugs
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the ophthalmology drugs market.
Major competitors in the ophthalmology drugs market include Novartis AG, Regeneron Pharmaceuticals, Inc., Allergan plc, Bayer AG, Santen Pharmaceutical Co., Ltd.
See The Full Ophthalmology drugs market Report Here:
The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.
The Table Of Content For The Ophthalmology drugs market Include:
1. Ophthalmology Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
29. Market Background: Pharmaceutical Drugs Market
30. Global Ophthalmology Drugs Market Opportunities And Strategies
31. Ophthalmology Drugs Market, Conclusions And Recommendations
33. Copyright and Disclaimer
The Business Research Company's "Global Ophthalmology Drugs Opportunities And Strategies Market Report - Forecast To 2030" is the most comprehensive report available in market, providing data and statistics from over 60 geographies analyzed in more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. Additionally, it evaluates the market's historic and projected growth and identifies significant trends and strategies that can be used to outperform the competitors in the sector.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
Healthcare Blog: https://healthcareresearchreports.com/
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmology Drugs Market 2022: SWOT Analysis Of Key Driving Factors For Growing CAGR Value | Novartis AG, Regeneron Pharmaceuticals, Inc., Allergan plc, Bayer AG here
News-ID: 2793966 • Views: 153
More Releases from The Business research company
Vertical - Specific Software Market Insights, Trends, Segments And Global Foreca …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the vertical - specific software minerals market report by The Business Research Company, The adoption of 5G technology is expected to propel the growth of the vertical-specific software market going forward. 5G is the fifth generation of mobile networks that enables a new type
Therapeutic Nutrients And Minerals Market Trends, Growth, Major Players Analysis …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the therapeutic nutrients and minerals market report by The Business Research Company, The rising demand for immunity-boosting products is expected to propel the growth of the therapeutic nutrients and minerals market going forward. Immunity-boosting products are dietary supplements, foods, or beverages that improve or
Networking Support Services Market Trends, Top Companies, Share, Growth And Fore …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Networking Support Services Market Size, Growth Rate, And Forecast The global networking support services market size is expected to grow from $838.14 billion in 2022 to $886.56 billion in 2023 at a compound annual growth rate (CAGR) of 5.8%. The Russia-Ukraine war disrupted the chances of global
Household Natural Gas Distribution Market
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Household Natural Gas Distribution Market Size, Growth Rate, And Forecast The global household natural gas distribution market size is expected to grow from $169.49 billion in 2022 to $179.20 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug